Lifeline Cell Technology and Lifeline Skin Care, increased to $2.39 million, an increase of 29%, compared to $1.85 million in 2023. Loss from operations decreased to $68,000 for the year ended ...

SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / International Stem Cell Corporation (OTCQB:ISCO) ( ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing ...